Search Results
Found 1 results
510(k) Data Aggregation
(197 days)
RINGLOC + HYBRID ACETABULAR SYSTEM
The Porous Plasma Spray (PPS) Ringloc + Acetabular System is intended to replace the natural acetabulum damaged by disease, trauma or revision of previous arthroplasty.
Indications For Use:
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
- Rheumatoid arthritis
- Correction of functional deformity
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
- Revision procedures where other treatment or devices have failed.
The Porous Plasma Spray (PPS) Ringloc + Acetabular System is intended for uncemented use only.
The Porous Plasma Spray (PPS) Ringloc + Acetabular System is a series of acetabular shells that incorporate the Ringloc + locking mechanism design of the predicate Regenerex Ringloc 4 Modular Acetabular Shells. The Porous Plasma Spray (PPS) Ringloc + Acetabular System shells are compatible with Biomet's M2a Ringloc® Acetabular Liners or the conventional Ringloc® UHMWPE liners that are currently on the market. The subject Porous Plasma Spray (PPS) Ringloc®+ Acetabular System shells are made of titanium alloy conforming to ASTM F-136 with a porous plasma spray outer surface coating of titanium alloy powder conforming to ASTM F-1580.
The provided text is a 510(k) summary for a medical device (Porous Plasma Spray (PPS) Ringloc+ Acetabular System). It does not describe a study to prove a device meets acceptance criteria related to an AI/ML algorithm or its performance.
Instead, this document focuses on demonstrating substantial equivalence to predicate devices, which is a regulatory pathway for certain medical devices.
Therefore, most of the requested information regarding acceptance criteria, study design, ground truth, expert involvement, and sample sizes for AI/ML performance evaluation is not applicable to this document.
However, I can extract the following relevant information:
- Device Name: Porous Plasma Spray (PPS) Ringloc+ Acetabular System
- Purpose of filing: To demonstrate substantial equivalence to legally marketed predicate devices.
- Key finding related to "testing": "Since the locking mechanism of the subject and predicate devices is identical, no testing was required to demonstrate substantial equivalence of the Porous Plasma Spray (PPS) Ringloc + Acetabular System to the predicate Regenerex Ringloc + Modular Acetabular..."
Since no performance study in the context of AI/ML was conducted or described, I cannot fill in the requested table and details. The document explicitly states "no testing was required" due to the identical locking mechanism with the predicate device.
Ask a specific question about this device
Page 1 of 1